483 Roundup: FDA Cites Five Firms for Quality Failures By Sam | April 8, 2020 FDA investigators found a wide range of GMP deficiencies during inspections of a Biocon facility in India and at four U.S. plants. Source: Drug GMP Report Posted in Drug GMP Report